Taurolock Hep500™

4% citrate (anti-clotting effect), 1.35% taurolidine (broad antimicrobial activity incl. MRSA and VRE) and 500 units of heparin per mL (extra anticoagulant effect)

Specifications Taurolock Hep500™

Catheter lock solution with double effectiveness

TauroLock™ is a preventive lock solution suitable for central venous access within hemodialysis and oncology. In order to ensure a catheter with an optimum blood flow, it is important that the lock solution ensures both clotting and infection prevention. Taurolock’s double effectiveness prevents catheter infections and clot formation.

The double effectiveness of TauroLock Hep500* consists of the combination of:

  • Taurolidine, prevents bacterial growth and biofilm formation
  • 4% citrate, anti-clotting effect
  • Heparin 500 units per mL, extra anti-clotting effect

* Also available Taurolock Hep100 with 100 units of heparin per mL

Description: 4% citrate (anti-clotting effect), 1.35% taurolidine (broad antimicrobial activity incl. MRSA and VRE) and 500 units of heparin per mL (extra anticoagulant effect)

Appearance: Glass ampoule, 5 mL

Package size: 10 items

Z-index number: 15716287

Item number: 1000407

Manufacturer: Tauropharm

More information?

Receive the available brochures and/or papers

Please enable JavaScript in your browser to complete this form.

Contact us

Please enable JavaScript in your browser to complete this form.

Cablon Medical has developed a lead apron configurator that allows you to put together your own lead apron.